Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682342 · ClinicalTrials.gov registry record
Hyperglycemia and Mitochondrial Function in The Endothelium of Humans
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 35
- Enrollment target
NCT02682342 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 35 participants.
The verdict
NCT02682342 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
In this study, the investigators will test the hypothesis that acute in vivo exposure to hyperglycemia increases mitochondrial network fragmentation and mitochondrial reactive oxygen species production (ROS) production in human arterial endothelial cells.
Interventions
- OTHER 75 g glucose solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-03-09 |
| Est. Completion | 2022-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682342
The ClinicalTrials.gov registry entry for NCT02682342 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 75 g glucose solution is the first listed.
NCT02682342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02682342 about?
NCT02682342 is a clinical study titled "Hyperglycemia and Mitochondrial Function in The Endothelium of Humans". In this study, the investigators will test the hypothesis that acute in vivo exposure to hyperglycemia increases mitochondrial network fragmentation and mitochondrial reactive oxygen species production (ROS) production in human arterial endothelial cells.
What is the current status of trial NCT02682342?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2016-03-09. Estimated completion is 2022-11-22.
What interventions are being tested in trial NCT02682342?
The interventions under investigation include: 75 g glucose solution (OTHER).
Who is sponsoring clinical trial NCT02682342?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.